BRG1 (Brahma-Related Gene 1), encoded by SMARCA4, is the ATPase subunit of the SWI/SNF (SWItch/Sucrose Non-Fermentable) chromatin remodeling complex. This complex uses the energy of ATP hydrolysis to slide, evict, or restructure nucleosomes, dynamically regulating DNA accessibility for transcription, DNA repair, and replication. BRG1 is essential for development, neuronal differentiation, and synaptic plasticity, and its dysfunction has been implicated in Alzheimer's disease, Parkinson's disease, and cancer.
BRG1 protein is the central catalytic engine of the SWI/SNF complex, one of the most important epigenetic regulators in eukaryotes. The SWI/SNF complex remodels chromatin by altering nucleosome positions, thereby controlling access to DNA for transcription factors, DNA repair machinery, and the transcriptional machinery. BRG1-containing complexes regulate thousands of genes, with particular importance in neuronal development and function.
| Property |
Value |
| Protein Name |
BRG1 (SMARCA4) |
| Gene |
SMARCA4 |
| UniProt ID |
P51532 |
| PDB ID |
6EFA, 6GRG |
| Molecular Weight |
185 kDa |
| Subcellular Localization |
Nucleus (chromatin-associated) |
| Protein Family |
SNF2 superfamily, SWI/SNF family |
| Aliases |
BRG1, SNF2L4, BAF190, SMARCA4 |
BRG1 contains characteristic domains:
- N-terminal domain - Protein interaction motifs, including Bromo domain
- ATPase domain - SNF2-type helicase domain with two RecA-like lobes
- HSA domain - Actin-binding region
- C-terminal domain - Conserved SNF2-specific motifs
The ATPase domain adopts a bipartite structure typical of chromatin remodelers, with a hinge region allowing conformational changes during the remodeling cycle.
BRG1 in the nervous system:
- Chromatin remodeling - Opens chromatin for transcription
- Neuronal differentiation - Controls developmental gene programs
- Synaptic plasticity - Regulates activity-dependent genes
- DNA repair - Facilitates access to DNA damage sites
- Cell cycle - Controls G1/S transition
BRG1/SMARCA4 dysfunction in AD:
- Amyloid metabolism - Regulates APP transcription
- Tau pathology - Controls tau-related gene expression
- Synaptic plasticity - Activity-dependent transcription impaired
- Neuroinflammation - Alters microglial gene expression
- Epigenetic decline - SWI/SNF function declines with age
BRG1 involvement in PD:
- Alpha-synuclein - Controls SNCA gene expression
- Mitochondrial function - Regulates PGC-1α and mitochondrial biogenesis
- Dopaminergic neurons - Essential for DA neuron development
- DNA repair - Impaired in PD models
SMARCA2 (BRM, BRG1's paralog) mutations cause Rett-like syndrome:
- MECP2 interaction - SWI/SNF works with methyl-CpG binding proteins
- Synaptic dysfunction - Abnormal synaptic gene regulation
- Therapeutic approaches - HDAC inhibitors as potential treatment
SMARCA4 is a major tumor suppressor:
- Loss-of-function mutations in lung, brain, and colon cancers
- Synthetic lethality - Vulnerable to EZH2 inhibitors and other targeted therapies
- Kadoch et al., Dynamics of BAF, SWI/SNF chromatin remodeling complexes, Nature Reviews Cancer (2016)
- Bachmann et al., SMARCA4/BRG1 in neurological diseases, Human Molecular Genetics (2018)
- Mueller et al., BRG1 regulates neuronal gene expression in Alzheimer's disease, Journal of Alzheimer's Disease (2019)
- Wang et al., SWI/SNF complexes in Parkinson's disease models, npj Parkinson's Disease (2020)
- Stokes et al., Structure of the NuRD complex, Nature (2015)
- Millard et al., CHD4 and NuRD in cancer, Nat Rev Cancer (2019)
- Zhang et al., CHD5 tumor suppressor, Cancer Cell (2017)
- Hu et al., BRG1 in neurodegeneration, J Neurosci (2020)
- D'Alessio et al., CBX7 in aging and cancer, Aging Cell (2018)